INTRODUCTION
result in the development of increased sensitivity to drugs percentage (60%) of Gulf War veterans (Miller, 2000) as well as agricultural workers suffering acute organophosphate intoxication developed long-term intolerance to nicotine and ethanol-containing beverages (Tabershaw and Cooper, 1966) . Moreover, we reported that Wistar rats administered with a single high dose of the organophosphate CPF exhibit a reduction in voluntary ethanol consumption eight weeks post-administration and increased ethanol sedation, at a time when cerebral AChE activity was mostly recovered .
OPs disrupt the functioning of certain neurotransmitter systems critically involved in ethanol consumption, as the dopaminergic and the cannabinoid system (Gralewicz et al., 2002; Moreno et al., 2008; Quistad et al., 2001 Quistad et al., , 2002 Rocha et al., 1996; Sanchez-Amate et al., 2002) . Three weeks after acute exposure to the chlorphenvinphos OP, behavioural responsiveness to amphetamine and scopolamine (Gralewicz et al., 2002) were reported. In the case of cannabinoid system, chlorpyrifos oxons potentiate the cannabinoid activity of anandamide in mice (Quistad et al., 2001) , probably because it inhibits 50% of the FAAH activity (Quistad et al., 2002; Liu et al., 2013) Also, OPs modify the formation and/or degradation of some neuropeptides (Slotkin and Seidler, 2010 ) with a known role in voluntary consumption of alcohol (Rada et al., 2004; Schneider et al., 2007; Thiele et al., 2003) . Thus, in vitro studies showed that chlorpyrifos evoked a robust upregulation of corticotropin releasing hormone, galanin or neuropeptide Y (Slotkin and Seidler, 2010) .
Additionally, several studies showed that chron--els of dopamine (Corominas et al., 2007; Smith et al., 2008) and increased levels of endocannabinoids (Basavarajappa and Hungund, 1999; Basavarajappa et al., 2000; Colombo et al., 2002) . Besides, levels of orexin mRNA (Morgansterm et al et al., 2010) were reduced and levels of opioid encephalin and galanin were increased (Chang et al., 2007 by chronic exposure to ethanol.
Bearing in mind the impact of OP on several neurochemical and/or neuromodulators systems, which in turn can be altered by continued ethanol intake, the main objective of this work is to evaluate whether a history of -tary alcohol consumption previously described in our lab . For that aim, we evaluated ethanol consumption for eight weeks in ethanol pre-exposed and ethanol naïve animals treated with a single high dose of CPF. Additionally, in previous studies we found that CPF altered feeding without an impact on body weight gain and reduces basal c-fos expression in the arcuate hypothalamic nucleus (Carvajal et al., 2014) , a brain region were feeding neuropeptides are produced. Additionally, given these data and that neuropeptides affected by OP and ethanol intake have also an important role in feeding (for a review, see Boughton and Murphy, 2013) , we will analyse if CPF alters food intake under experimental conditions used in this study.
MATERIAL AND METHODS

Animals
Male Wistar albino rats (Charles River Laboratories, Barcelona, Spain) weighing 300-350 g at the beginning of the experiments were housed individually and maintained in an environmentally controlled room (22°C temperature on a 12:12 hr light-dark cycle). Food and water were provided ad libitum. Behavioural procedures and pharmacological techniques were approved by the Bioethical animal care committee at the University of Almeria, Spain. They were in agreement with the animal care guidelines established by the Spanish Royal Decree 1025/2005 for reducing animal pain and discomfort.
CPF administration
After 15 days of habituation to the laboratory conditions, the animals in experiment 1 were weighed and homogeneously distributed into two groups, CPF group (n = 16), that received a single sc injection of CPF (O, 5, phosphorothioate, 99.5%, Riedel-de Haën, Germany, dissolved in olive oil, 250 mg/kg in 1 ml/kg), and VEH group (n = 14), that received a sc injection of olive oil (1 ml/kg) as vehicle. In experiment 2, following 15 days of habituation to the laboratory conditions and prior to experimental treatment with CPF, animals were exposed for 3 weeks to unlimited 24-hr free access to an ethanol solution (8 % w/v) and water in a two bottle procedure. After continued ethanol consumption for three weeks, the animals were weighed and homogeneously distributed into two groups based on daily averaged ethanol consumption and treated with CPF (n = 18) or vehicle (n = 13) as described above. We did not perform a dose-response study for two main reasons. First, the dose of CPF chosen in the study elicits maximum brain AChE inhibition (close to 90% inhibition 4 days post-poisoning) and keeps AChE mildly inhibited for weeks without overt signs of toxicity; adding additional doses of the compound unnecessary increase the total number of animals in the study; second, although this is a sub-clinical dose, it triggers delayed long-last- Vol. 39 No. 3 ing disturbances in ethanol consumption , reduces neural activity (Carvajal et al., 2005 (Carvajal et al., , 2014 and blunts dopaminergic and serotonergic function 30 days post-administration (Moreno et al., 2008) .
Voluntary ethanol consumption
In experiment 1 the animals were exposed for seven weeks to an ethanol-drinking schedule starting four days post-CPF or VEH administration consisting of 24-hr free access to two bottles, one containing plain water and the other containing a solution of ethanol diluted in plain water. Wistar rats usually prefer low ethanol concentrations (6%-8%) (Beardsley et al., 1978) ; however, there is ample evidence showing that pharmacological manipulations of a number of neurochemical systems may enhance voluntary consumption of non-preferred, highly concentrated (15%-20%) ethanol solutions that otherwise are spontaneously avoided (Files et al., 1995; Slawecki and Samson, 1997) . We tested here whether CPF treatment alters voluntary consumption of two progressively increasing ethanol concentrations. To that end, in experiment 1 8% w/v ethanol was presented for five weeks, so the animals had the opportunity to stabilize their daily intake, and then ethanol shifted to 15% w/v on weeks 6-8 (see Fig. 1a for temporal details).
In experiment 2, the animals were pre-exposed to continued 8% w/v ethanol drinking for three weeks before CPF or VEH treatment and then, for two additional ethanol was shifted to 15% w/v for two additional weeks. Given that CPF treatment altered voluntary 15% w/v ethanol drinking (see results section), an additional 20% w/v ethanol concentration was tested for two more weeks (see Fig. 1b for temporal details).
While animals were exposed to ethanol, the positions of the bottles were changed every two days to control position preferences. In order to obtain a measure of ethanol consumption correcting individual size differences in the rats, the index "g ethanol/kg/24 hr" was calculated. As a measure of relative ethanol preference, we calculated an ethanol preference ratio by dividing the volume of ethanol solution consumed by the total volume food intake (g/kg/24 hr) and BW (weekly average) were carefully recorded. In all cases, a weekly average of 24-hr consumption/preference measures was calculated for statistical analysis.
Brain acetylcholinesterase determination
A single dose of CPF (250 mg/kg) induces a maximum brain AChE inhibition 48 hr post-administration (Cardona et al., 2006; Lopez-Crespo et al., 2007) , remaining inhibited at similar extent 4 days post-administration and slowly recovering over a period of approximately twelve weeks (Bushnell et al., 1993) . In the present study biochemical indexes of CPF intoxication were collected at two different time-points. Thus, brain AChE inhibition by animals with a previous history of ethanol consumption (EE group) and animals without a previous history of ethanol consumption (EN group) was analyzed four and five weeks post-CPF/VEH administration (when altered ethanol consumption was observed) by spectrophotometric methods. For that aim, animals (n = 5) in CPF and VEH groups were randomly selected for cerebral AChE assays. The animals in each group were anesthetized with pentothal sodium (80 mg/kg in 1 mg/kg volume) and then decapitated. The whole brain was removed and immediately homogenized with 1% Triton X-100 in 0.1 M Na phosphate buffer at Ph 8 at a ratio of 1/10 (wt/ vol). The homogenate was centrifuged at 1,000 × g for 10 min; then the pellet was discarded and the supernatant was kept for AChE assay. AChE activity was determined Vol. 39 No. 3 by spectrophotometer (DU 530 Beckman spectrophotometer) by the Ellman method (Ellman et al., 1961) using tetraisopropyl pyrophosphoramide (iso-OMPA, specif--concentration 0.5 mM) as substrate and 5,5-dithiobis-2-nitrobenzoic acid (DTNB) (200 l; final concentration 0.33 mM). Assay tubes were completed to 1 ml with Na phosphate buffer pH 8. Enzyme activity was calculated relative to protein concentration by the Bradford method (Bradford, 1976) . For biochemical assays, acetylthiocoline iodide, iso-OMPA and DTNB were purchased from Sigma-Quimica, Madrid, Spain.
Statistics
Weekly average ethanol intake (g/kg/24-hr), food intake (g/kg/24-hr) and ethanol preference (ml ethanol/ -pendent treatment x week repeated-measures analysis of variance (ANOVA). Treatment main factor examined differences between CPF and VEH group. Week main factor compared consumption (food, ethanol, fluid), ethanol preference and BW over the testing time; because the week factor did not provide any relevant information for -tions emerged, pair-wise comparisons by post-hoc Newman-Keuls test (NK) were carried out. The accepted level
RESULTS
Effects of CPF exposure on voluntary ethanol consumption, ethanol preference and food consumption in animals without a previous history of ethanol consumption (EN group) Consumption measures while drinking 8% w/v ethanol solution (weeks 1-5)
Four days post-CPF administration, the animals had 24-hr free access to 8% w/v ethanol solution and plain water for five weeks (see Fig. 1a for temporal details). Independent 2 x 5 (treatment x week) repeated measures ANOVA were performed on weekly average ethanol, weeks. The ANOVA conducted on ethanol intake data showed no statistically relevant differences of treatment (F (1, 19) = 0.35; p > 0.05) or treatment x week interaction (F (4, 76) = 1.37; p > 0.05), indicating that CPF treatconsumption relative to VEH treatment (Fig. 2a) . In the same direction, the ANOVA conducted on ethanol preference (F (1, 19) = 2.74; p > 0.05) or treatment x week interaction (F (4, 76) = 1.11; p > 0.05) (Fig. 2b) . The ANO-VA conducted to compare food intake in CPF-treated rats relative to VEH-treated rats yielded a significant treatincreased food consumption in CPF-treated rats. No sigp > 0.05) was observed (Fig. 2c) .
Consumption measures while drinking 15% w/v ethanol solution (weeks 6-8)
On weeks 6-8, ethanol concentration was shifted to 15% w/v. Weekly average consumption data during this two-week period was analyzed by independent 2 x 3 (treatment x week) repeated measures ANOVA. CPF-and VEH-treated animals did not differ in ethanol consumption as revealed by the ANOVA conducted on ethanol intake measures that showed no statistical significance of treatment (F (1, 19) = 1.21; p > 0.05) or treatment x week interaction (F (2, 38) = 1.6; p > 0.05) (Fig. 2d) . Additionally, the ANOVA conducted on ethanol preferences (F (1, 19) = 0.2; p > 0.05) or treatment x week interaction (F (2, 38) = 1.8; p > 0.05) (Fig. 2e) . The ANOVA carried out to evaluate food intake while drinking 15% w/v eth--ment main effect (F (1, 19) = 0.03; p > 0.05) or treatment x week interaction (F (2, 38) = 0.5; p > 0.05) (Fig. 2f) .
Body Weight in the EN group
Weekly average BW data collected for eight weeks post-CPF poisoning in EN rats were analysed by independent 2 x 8 (treatment x week) repeated measures ANOVA that evaluated body weight evolution in CPFand VEH-treated rats for eight weeks. The ANOVA conducted on data showed similar BW in CPF-and VEHtreated rats over this period, treatment (F (1, 19) = 0.4; p > 0.05), treatment x week interaction (F (7, 133) = 0.2; p > 0.05), (Fig. 3) . and VEH-treated rats at any time-point tested, indicating that CPF treatment did not significantly alter 8% w/v ethanol drinking relative to VEH treatment (Fig. 4a) . The ANOVA conducted to evaluate ethanol preference in CPF-relative to VEH-treated rats while drinking 8% w/v ethanol solution did not show statistical p > 0.05). The treatment x week interaction attained sta--er, additional post-hoc analysis showed no significant differences between CPF and VEH in their ethanol preference ratio along the two time-points tested (NK > 0.05) (Fig. 4b) . The ANOVA conducted on food consumption data obtained while drinking 8% w/v ethanol solution yielded a significant treatment x week interaction NK tests revealed that no significant group differences emerged at any time-point tested (Fig. 4c) . 
Consumption measures while drinking 15% w/v ethanol solution (weeks 3-5 post-treatment).
Following five weeks of continued 8% w/v ethanol access, (see Fig. 1b for temporal details) , the ethanol concentration was shifted to 15% w/v and additional measures were collected for 3 more weeks. Weekly average consumption data were analyzed by independent 2 x 3 (treatment x week) repeated measures ANOVAs. The ANOVA performed on ethanol intake data revealed higher ethanol consumption by CPF-treated rats relative to VEH-treated animals on weeks 3-5 (treatment -p > 0.05) (Fig. 4d) . The ANOVA conducted on ethanol preference measures revealed that CPF-treated rats displayed significantly higher preference for ethanol con- in CPF-and VEH-treated rats achieved a similar level, treatment (F (1, 29) = 0.4; p > 0.05). The ANOVA conducted on food consumption data revealed that CPF-treat--tion compared to VEH-treated rats while consuming 15% w/v ethanol on weeks 3-5, (treatment (F (1, 29) = 7.6;
Consumption measures while drinking 20% w/v ethanol solution (weeks 6-7 post-treatment)
On weeks 6-7, the animals were offered 24-hr free access to a 20% w/v ethanol solution and water. Independent 2 x 2 (treatment x week) repeated measures ANOVA were performed on weekly averaged consumption data. The ANOVA conducted on ethanol intake data main effect. The treatment x week interaction did not (Fig. 4g) . The ANOVA conducted on ethanol preference measures revealed that CPF-treated rats continued disethanol solution relative to VEH-treated rats, treatment -tion (F (2, 58) = 2.4; p > 0.05) did not attain statistical sigon total fluid data revealed that CPF-and VEH-treatwhile consuming ethanol at 20% w/v, treatment (F (1, 29) = 0.7; p > 0.05), (data not shown). Finally, the ANOVA performed on food intake data revealed that CPF animals -pared to VEH-treated rats while consuming 20% ethanol treatment x week interaction did not attain statistical sig-
Body Weight in the EE group
Weekly average body weight data in EE rats collected for seven weeks post-CPF poisoning were analysed by a 2 x 7 (treatment x week) repeated measures ANOVA that compared BW evolution in CPF-and VEH-treated rats.
tional post hoc NK analysis revealed lower BW in CPFtreated rats during the first week of testing. No further significant group differences were found in BW at any time-point tested (Fig. 5 ).
Brain AChE activity in CPF-and VEH-treated rats in the ethanol pre-exposed (EE) and the ethanol-naïve (EN) groups was measured in two parallel groups of randomly selected rats, four days (when AChE inhibition peaks) altered feeding and ethanol consumption was observed in CPF-treated rats, by independent two-way 2 x 2 (treatment x group) ANOVAs.
AChE inhibition 4 days post-CPF poisoning
The analysis conducted on AChE data four days posttreatment revealed a statistically significant effect of -ty: EN group (animals without a previous history of eth-EE group (animals with a previous history of ethanol conAChE activity was 82.04% and 74.88% inhibited in the EN and EE groups, respectively (Fig. 6 ). Neither the group main factor nor the treatment x group interaction attained statistical significance: F (1, 16) = 2.06; p > 0.05 and F (1, 16) = 2.45; p > 0.05, respectively. min. Thus, AChE activity was 55.43% and 43.73% inhibited in the EN and EE groups, respectively (Fig. 6) . Neither the group main factor nor the treatment x group interp > 0.05 and F (1, 16) = 3.27; p > 0.05, respectively, indicating similar levels of AChE inhibition in the EE and EN
DISCUSSION
In previous studies, we have demonstrated that exposure to a single high dose of CPF reduces voluntary ethanol consumption eight weeks post-intoxication . The present study was aimed to explore whether a previous history of alcohol consumption mod-reported by our lab .
istration of CPF to animals with a previous history of continued low ethanol drinking caused a delayed and moderate enhancement in voluntary ethanol consumption and ethanol preference compared to VEH-treatment, at high (15% and 20% w/v) but not low (8% w/v) ethanol concentrations, that lasted for 5 weeks. The observashown). Importantly, the same dose of CPF administered to animals that were ethanol-naïve at the time of CPF poiethanol avoidance and reduced ethanol preference for 3 weeks. No differences were found in levels of cerebral AChE inhibition between EE and EN CPF-treated rats, -ing that both groups were exposed to similar levels of the pesticide. Additionally, it indicates that differences in ethanol consumption emerging in ethanol-exposed vs ethanol naïve rats treated with CPF are unrelated to levels of cerebral AChE inhibition. However, bearing in mind recent studies showing variations in AChE-S mRNA and AChE-R mRNA levels after CPF exposure in the absence of changes in the corresponding enzyme activity (LopezGranero et al., 2014) , further testing is needed to specalled acylpeptide hydrolase (APH) seems to be more sensitive than AChE to CPF exposure (Cardona et al., 2013) , so it could be an alternative mechanism of CPF to study in future research.
The observation that pre-exposure to continued ethanol intakes before CPF administration increases ethanol consumption suggests the interesting hypothesis that alcohol and CPF might share some neurobiological targets. In par-CPF share some metabolic peripheral systems in the liver, and secondly, that ethanol acts on certain neurotransmitter systems and neuromodulators that are also biological targets of CPF. Therefore, both toxics may interact in different biological levels with summative and/or subtractive effects. Thus, the study of different neurobiological and peripheral substrates commons to CPF and ethanol the impact of CPF on voluntary ethanol consumption in the different circumstances of the interaction of OPs with during the testing period (7 weeks) while drinking ethanol at different concentrations (8% weeks 1-2; 15% weeks 3-5; 20% weeks 6-7). CPF group reduced BW -were found on BW during the rest of the testing period exposure to the drug. In the present study, the effect of CPF on the ethanol consumption is mediated by prior exposure to alcohol in the case of pre-exposed animals. Therefore, chronic ethanol exposure may be affecting neurochemical systems as the dopaminergic or GABAergic (Diaz et al., 2011; Smith et al., 2008) , and/or neuromodulators such as the cannabinoid system (Basavarajappa and Hungund, 1999; Basavarajappa et al., 2000) that are also neurobiological targets of CPF. Moreover, both dopaminergic and cannabinoid system have a key role in voluntary ethanol intake (Casu et al., 2002; Colombo et al., 2002; Erdozain and Callado, 2011; Samson et al., 2002) . In this regard, several studies showed that chronic exposure to alcohol as the administration of CPF lead to decreased levels of dopamine (Gralewitz et al., 2002; Moreno et al., 2008; Smith et al., 2008) and increased levels of endocannabinoids Liu et al., 2013; Quistad et al., 2001 Quistad et al., , 2002 . Thus, pharmacological manipulations that trigger a decrease in dopamine levels (Izco et al., 2007; Olive et al., 2002; Rassnick et al., 1999) or increased levels of endocannabinoids Erdozain and Callado, 2011) cause an increase in ethanol consumption. Thus, our data of increased alcohol consumption following administration of CPF to animals with a history of ethanol intake may be the result of a summative effect of the effects of CPF administration and chronic ethanol exposure on the dopaminergic and/or cannabinoid system.
On the other hand, we cannot rule out the potential effect of ethanol consumption on metabolic processes shared by ethanol and CPF. Thus, the ethanol can increase the levels of paraoxonase 1 (PON1) (Costa et al., , 2010 Rao et al., 2003) , a polymorphic enzyme responsible to hydrolyze the active metabolites of CPF (CPF-oxon) to inactive compounds Li et al., 1995) . In this way, the existence of a history of alcohol consumption prior to the administration of CPF could -tion of organophosphorus compound and consequently its impact on various behaviors, such as the voluntary consumption of alcohol. In fact, several studies using transgenic mouse models founded that paraoxonase plays a key role in modulating the acute toxicity of certain OPs, such as CPF Li et al., 2000) .
Surprisingly, CPF-treated rats showed enhanced food intake independently of the existence or not of a previous history of ethanol drinking. By other hand, the observation that long-lasting increments in feeding were not folinduced a primary energy balance disturbance. The fact that CPF triggered augmented feeding with no changes in BW is consistent with recent experimental evidence showing that neonatal organophosphate exposure causes long-lasting effects on metabolism that might contribute to the development of obesity and diabetes (Lassiter and Brimijoin, 2008; Meyer et al., 2004; Slotkin et al., 2005) . In the same direction, chronic exposure to the OP chlorpyrifos (CPF) in adult rats increased body weight gain (Meggs and Brewer, 2007) ; additionally, CPF triggered a biphasic response in neonates, with enhanced BW gain at low doses, whereas the effect was lost at higher doses (Lassiter and Brimijoin, 2008) . Furthermore, neonatal CPF exposure altered the programming of metabolic function (Meyer et al., 2004) and exposure of neonatal rats to parathion elicited sex-selective and dose-dependent metabolic disturbances . Present data add interesting information by suggesting that a single high dose of CPF elicits energy unbalance in adult male rats while drinking ethanol.
In conclusion, the main finding of the present study is that combined pre-exposure to ethanol, voluntarily ingested at not intoxicating doses, and CPF administration have a synergic action to impair voluntary ethanol intake in rats. Thus, the voluntary ethanol preference and ethanol intake was augmented at high ethanol concentrations in adult male CPF-treated rats with a previous history of low ethanol drinking. Importantly, present data prochronic ethanol drinking, even at low levels, modulates the effects of CPF on voluntary ethanol intake and ethanol preference. Our present data cannot clarify specific mechanism underlying this effect. However, the search CPF toxicity underlying the interaction between OP and pointing to the potential impact of low/moderate social drinking in humans eventually exposed to environmental pollutants such as organophosphates.
